HC Wainwright Sees Over 300% Upside In This Cancer-Focused Stock
HC Wainwright has initiated Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating and a price target of $22 (310% upside). The analysts see…
Raymond James Thinks Haemonetics Growth Is ‘Underappreciated’
Earlier this week, Raymond James attended Haemonetics Corp’s (NYSE:HAE) Investor Day, where the management team presented a new Long-Range Plan (LRP), including…
B. Riley Securities Maintains Buy on PennyMac Mortgage, Lowers Price Target to $18
B. Riley Securities analyst Matt Howlett maintains PennyMac Mortgage (NYSE:PMT) with a Buy and lowers the price target from $21 to $18.
RBC Capital Maintains Sector Perform on Enanta Pharmaceuticals, Raises Price Target to $67
RBC Capital analyst Brian Abrahams maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Sector Perform and raises the price target from $64 to $67.
Craig-Hallum Maintains Buy on II-VI, Lowers Price Target to $80
Craig-Hallum analyst Richard Shannon maintains II-VI (NASDAQ:IIVI) with a Buy and lowers the price target from $85 to $80.
Canaccord Genuity Maintains Sell on Canopy Gwth, Lowers Price Target to C$3.5
Canaccord Genuity analyst Matt Bottomley maintains Canopy Gwth (TSX:WEED) with a Sell and lowers the price target from C$4.5 to C$3.5.
DA Davidson Maintains Neutral on Summit Materials, Lowers Price Target to $26
DA Davidson analyst Brent Thielman maintains Summit Materials (NYSE:SUM) with a Neutral and lowers the price target from $33 to $26.
DA Davidson Maintains Buy on Envestnet, Lowers Price Target to $70
DA Davidson analyst Peter Heckmann maintains Envestnet (NYSE:ENV) with a Buy and lowers the price target from $86 to $70.
Evercore ISI Group Maintains Outperform on Etsy, Lowers Price Target to $95
Evercore ISI Group analyst Shweta Khajuria maintains Etsy (NASDAQ:ETSY) with a Outperform and lowers the price target from $130 to $95.
Cowen & Co. Maintains Market Perform on Amphenol, Lowers Price Target to $73
Cowen & Co. analyst Jim Suva maintains Amphenol (NYSE:APH) with a Market Perform and lowers the price target from $80 to $73.